Related by context. All words. (Click for frequent words.) 75 BioDelivery 73 Regeneron Pharma 73 Alnylam Pharma 72 Anika Therapeutics 72 Milestone Payment 71 Inspire Pharma 71 Onsolis 71 Sunesis Pharmaceuticals 71 Milestone Payment From 71 Auxilium Pharma 70 Adventrx 70 Zenpep 69 Sunesis Pharma 69 Cyclacel Pharmaceuticals 69 Migenix 69 PDUFA Date 69 Milestone Payments 69 Durect 69 Par Pharma 69 Transcept Pharmaceuticals 69 Paladin Labs 69 MiddleBrook Pharmaceuticals 69 Testosterone Gel 69 Orapred ODT 69 Auxilium Pharmaceuticals 69 DOV Pharmaceutical 68 Rexahn Pharmaceuticals 68 BDSI 68 Progenics Pharmaceuticals 68 Vertex Pharma 68 FDA Approvable Letter 68 Somaxon Pharma 68 IND Filing 68 DepoMed 68 NDA Submission 68 Valeant Pharma 68 Million Milestone Payment 68 Idenix Pharmaceuticals 68 NASDAQ BDSI 67 CyDex Pharmaceuticals 67 Idera Pharmaceuticals 67 Novelos Therapeutics 67 Indevus Pharma 67 Trubion Pharma 67 Seattle Genetics SGEN 67 Eurand NV EURX 67 Cephalon NASDAQ CEPH 67 Salix Pharma 67 Harbor BioSciences 67 Trubion Pharmaceuticals TRBN 67 Rigel Pharmaceuticals 67 Isis Pharma 67 Patient Enrollment 67 Meets Primary Endpoint 67 NPS Pharma 67 Ariad Pharma 67 Emisphere Technologies 67 Zegerid OTC 67 FDA Accepts 67 Optimer Pharma 67 Fast Track Status 67 Depomed DEPO 67 AEterna 67 Arqule 67 Migraine Drug 67 Accentia Biopharmaceuticals 67 Auxilium Pharmaceuticals AUXL 67 Palatin Technologies 66 Altus Pharmaceuticals 66 PRAECIS PHARMACEUTICALS INCORPORATED 66 Mylan Receives Approval 66 Peregrine Pharma 66 Sciele Pharma 66 Generic Version Of 66 InNexus Biotechnology 66 Submits NDA 66 NGSX 66 Alnara Pharmaceuticals 66 Penwest Pharmaceuticals 66 Biodel BIOD 66 Angiotech Pharma 66 Ercole Biotech 66 Enzon Pharmaceuticals 66 Cornerstone Therapeutics 66 ISTA Pharmaceuticals 66 Optimer Pharmaceuticals 66 Oncolytics Biotech 66 Genelabs Technologies 66 Schizophrenia Drug 66 Praecis 66 Vion Pharmaceuticals 66 Receives Approvable Letter 66 Onyx Pharma 66 NASDAQ BPAX 66 BioMarin Pharma 66 Akela Pharma 66 Penwest Pharma 66 Somaxon Pharmaceuticals 66 Arno Therapeutics 66 Vicuron Pharmaceuticals 66 NASDAQ SLXP 66 Generic Version 65 Halozyme Therapeutics 65 Transition Therapeutics 65 Psoriasis Drug 65 Submits Response 65 AEterna Zentaris 65 Allergan NYSE AGN 65 Lexicon Pharmaceuticals 65 Phase III Trials 65 Vernalis plc 65 BPAX 65 Files Investigational 65 Aegerion 65 Expanded Indication 65 BioCryst Pharma 65 Trubion Pharmaceuticals 65 Keryx Biopharma 65 Gralise 65 BioSante Pharmaceuticals 65 Akorn Inc 65 SCHWARZ PHARMA 65 ACADIA Pharmaceuticals 65 Generic Lovenox 65 Emezine 65 WILEX 65 NOVAVAX 65 PROTONIX 65 Vanda Pharma 65 By JAMAAL ABDUL 65 Receive Milestone Payment 65 Marketing Authorisation Application 65 Protalix BioTherapeutics 65 Penwest Pharmaceuticals Co 65 Syntonix 65 BioSyent Pharma 65 Inhaled Insulin 65 Initiates Enrollment 65 Oscient Pharmaceuticals 65 DOV Pharmaceutical Inc. 65 CRTX 65 Rheumatoid Arthritis Drug 65 ZARS Pharma 65 Phase IIb Clinical Trial 65 BioMarin Pharmaceutical 65 COLAZAL R 65 Nasdaq SLXP 65 MBRX 65 Prostate Cancer Vaccine 65 Fresenius Biotech 65 TTHI 65 Orexo 65 Indaflex TM 65 AMAG Pharmaceuticals 65 Ziopharm 65 eResearchTechnology 65 Synerx Pharma 65 ImmunoVaccine Technologies 65 Sanctura XR 64 Idenix Pharma 64 Javelin Pharmaceuticals 64 Ardea Biosciences 64 Investigational Treatment 64 Proquin XR 64 ARCA Biopharma 64 Tezampanel 64 Taro Receives 64 Gout Drug 64 Valera Pharmaceuticals 64 Encysive Pharma 64 NovaBay Pharmaceuticals 64 Endo Pharma 64 Threshold Pharmaceuticals 64 Keryx Biopharmaceuticals 64 TRACON Pharmaceuticals 64 Curon Medical 64 Combunox 64 Genvec 64 Javelin Pharma 64 Eurand NV 64 ViroPharma VPHM 64 Nasdaq Deficiency Notice 64 Generic Protonix 64 Medicis Pharma 64 Phase IIb Trial 64 Eximias Pharmaceutical Corporation 64 Metabasis Therapeutics 64 Pharmos Corporation 64 Vaccinex 64 Shire plc SHPGY 64 Risperidone Oral Solution 64 BUPHENYL R 64 Receives Fast Track 64 Oncolys 64 AcelRx 64 Iomai Corporation 64 Nektar Therapeutics NKTR 64 InvaGen 64 RAPTIVA r 64 OSI Pharma 64 ESBATech AG 64 BEMA ® 64 Sciele Pharma Inc. 64 Phase 2b Clinical Trial 64 Sirion Therapeutics 64 Frova ® 64 Dynogen 64 Endo Pharmaceuticals NASDAQ ENDP 64 ZARS 64 AUXL 64 Lupus Drug 64 VIVUS VVUS 64 Aegera Therapeutics 64 Anacor 64 Alnylam Nasdaq ALNY 64 RYZOLT 64 Cutanea Life Sciences 64 LibiGel ® 64 Amag 64 Vaccine Adjuvant 64 DYAX 64 Portola Pharmaceuticals 64 Threshold Pharma 64 DARA BioSciences 64 Teikoku Pharma USA 64 Clinical Trial Data 64 ABII 64 Indevus Pharmaceuticals 64 Cornerstone Therapeutics Inc. 64 TSRX 64 Neose Technologies 64 NTII 64 DUSA Pharmaceuticals 64 Intellipharmaceutics 64 markets HP Acthar 64 Procyon Biopharma 64 Inhibitex 64 EKR Therapeutics 64 Alvine Pharmaceuticals 64 Shire Plc SHPGY 64 Affymax AFFY 64 Apricus Biosciences 64 XenoPort NASDAQ XNPT 64 Roche OTC RHHBY 64 Santhera 64 NASDAQ AKRX 63 Receives Complete Response 63 FDA Approvals 63 Generex Biotechnology 63 Savient Pharmaceuticals 63 Release Capsules 63 Phase III Clinical Trial 63 IV APAP 63 Resubmission 63 Endo Pharmaceuticals ENDP 63 Completes Patient Enrollment 63 Ligand Pharma 63 DOV Pharmaceuticals 63 Pacira 63 Cethromycin 63 Pliaglis 63 Prism Pharmaceuticals 63 Inovio Pharmaceuticals 63 Advancis Pharmaceutical 63 Cellegy 63 Liprotamase 63 Cellegesic 63 Novel Antibiotic 63 Array BioPharma 63 Exalgo 63 Enzo Biochem 63 Cubist Pharma 63 Cellegy Pharmaceuticals 63 Æterna Zentaris 63 KV Pharma 63 Nasdaq IMGN 63 Submits Biologics License Application 63 H3 Pharma 63 Ascent Therapeutics 63 Phase 2b Trial 63 Announcement acc 63 Spectrum Pharmaceuticals 63 Aegerion Pharmaceuticals 63 RAPTIVA 63 SHP.L 63 Poniard Pharmaceuticals 63 Announces Tentative Approval 63 Quark Pharmaceuticals 63 Loramyc 63 Advanced Magnetics 63 Alimera Sciences 63 Synta Pharma 63 NASDAQ ISTA 63 BEMA TM Fentanyl 63 Sciclone Pharmaceuticals 63 Palatin Technologies Inc. 63 ProEthic Pharmaceuticals 63 DVAX 63 Nycomed GmbH 63 Argatroban 63 Glufosfamide 63 Par Pharmaceutical Companies 63 Xenoport 63 Nasdaq IDIX 63 Regeneron REGN 63 Targanta 63 OMRIX Biopharmaceuticals 63 Onyx Pharmaceuticals NASDAQ ONXX 63 SynthRx 63 Nasdaq BDSI 63 Alnara 63 Urigen Pharmaceuticals 63 Welichem 63 Orphan Status 63 Phase 2a Trial 63 successfully commercialize Iluvien 63 QuatRx 63 OPTR 63 Ustekinumab 63 Epilepsy Drug 63 NSTK 63 Initiates Phase III 63 nasal calcitonin product 63 Nitec Pharma 63 Archemix 63 Sinobiopharma 63 Submits Supplemental 63 HCV Protease Inhibitor 63 Pivotal Phase III 63 Impax Labs 63 NYSE Amex PTN 63 Pain Therapeutics PTIE 63 NASDAQ INCY 63 Revises FY# Outlook 63 Anadys Pharmaceuticals 63 Generic Versions 63 Salix Pharmaceuticals 63 QIAGEN QGEN 63 Ridaforolimus 63 Ventrus 63 Akorn Strides 63 Genelabs Technologies Inc. 63 Romiplostim 63 SYCREST 63 CeNeRx BioPharma 63 Incyte Corporation 63 Hana Biosciences 63 Pegloticase 63 Stavzor 63 FDA approvable letter 63 Connetics Corporation 63 Endo Pharmaceuticals Nasdaq ENDP 63 Alkermes ALKS 63 Anadys Pharma 63 Alexion Pharma 63 Inc Therapeutic Competitors 63 Adenosine Therapeutics 63 Ambrilia Biopharma 63 Epiphany Biosciences 63 Marketing Authorisation Application MAA 63 BioMimetic Therapeutics NASDAQ BMTI 63 Civacir 63 NASDAQ ARRY 63 Rapinyl 63 Critical Therapeutics 62 Arpida 62 Lupin Pharmaceuticals Inc. 62 Galderma SA 62 Testim R 62 Inc. Nasdaq IMGN 62 ANDA Filing 62 Dose Escalation 62 Lev Pharmaceuticals 62 Ascend Therapeutics 62 Akela Pharma Inc. 62 Immunogen 62 Levoleucovorin 62 NASDAQ AEZS 62 Zorbtive TM 62 KOSN 62 DRAXIS 62 Lung Rx 62 Peregrine Pharmaceuticals 62 Nasdaq CADX 62 ENZON 62 Nipent R 62 PRIALT 62 Zirgan 62 RDYN 62 Response Genetics 62 Earns Milestone Payment 62 Sumavel DosePro 62 Vitrasert R 62 Addrenex Pharmaceuticals 62 PDL BioPharma 62 ImmunoCellular Therapeutics 62 Relypsa 62 Blood Pressure Drug 62 Roche Actemra 62 NASDAQ PGNX 62 NASDAQ AVNR 62 Lung Cancer Drug 62 NitroMist 62 NASDAQ ALNY 62 NASDAQ NABI 62 Celgene Thalomid 62 NASDAQ REGN 62 Barrier Therapeutics Inc. 62 Files IND 62 Immunomedics IMMU 62 Teva Pharma 62 Cerimon Pharmaceuticals Inc. 62 Cempra Pharmaceuticals 62 Lorus Therapeutics 62 SangStat 62 Dificid 62 UGNE 62 Receives Orphan Drug 62 Nasdaq Delisting Notification 62 DRRX 62 Inex Pharmaceuticals 62 AMEX DDD 62 CIP TRAMADOL ER 62 Zogenix 62 Employment Inducement Awards 62 Receives Milestone Payment 62 Preotact 62 STELARA TM 62 BRILINTA 62 Revises FY# Guidance 62 GNLB 62 CDP# 62 Cadence Pharmaceuticals 62 ARCALYST R 62 Bicifadine 62 Gamunex C 62 SOMX 62 Ketotransdel 62 ARQL 62 Covalon Technologies 62 NASDAQ ONXX 62 Granted Orphan Drug 62 BioMS Medical 62 Orphan Therapeutics 62 Xcytrin R 62 IMMU 62 Initiates Clinical 62 Oscient 62 LGND 62 SYN X 62 Urokinase 62 OGXI 62 NASDAQ VRTX 62 ONSOLIS 62 Cepheid CPHD 62 Receives Orphan Drug Designation 62 Repros Therapeutics 62 SciClone Pharma 62 Biosante Pharmaceuticals 62 GTOP 62 Nabi HB Intravenous 62 Zingo TM 62 Arthritis Drug 62 Cardiome Pharma 62 Ticagrelor 62 Neurobiological Technologies 62 POZN 62 METOZOLV ODT 62 Indevus 62 Oxcarbazepine 62 Lidoderm R 62 Onalta 62 Cannasat Therapeutics 62 Mark A. Sirgo 62 Seasonal Influenza Vaccine 62 Wellstat 62 Meda AB 62 Sigma Tau Pharmaceuticals 62 Questcor Pharmaceuticals 62 Crofelemer budesonide foam 62 Avanir 62 First Patient Treated 62 GTC NASDAQ GTCB 62 Nasdaq TARG 62 ZEGERID Capsules 62 NASDAQ MNTA 62 TRANSDUR ™ 62 Furiex Pharmaceuticals 62 NeuroMedix 62 Valeant Pharmaceuticals NYSE VRX 62 Besivance 62 Hoyoung Huh 62 PCRX 62 Dynavax Technologies 62 NASDAQ VRUS 62 EPCT 62 Eyetech Pharmaceuticals 62 Sunshine Biopharma 62 Psivida 62 Alaven 62 Axcan Pharma 62 Xolegel 62 Relistor 62 Ariad Pharmaceuticals 62 Chemokine 62 Alliant Pharmaceuticals 62 Qutenza TM 62 Aldara ® 62 NASDAQ OGXI 62 Napo Pharmaceuticals 62 Nuvo Research 62 Varespladib 62 Nebido 62 Synera 62 Depomed 62 Paladin Labs Inc. 62 Furiex 62 RTI Biologics 62 SciClone Pharmaceuticals 62 Coley Pharmaceutical Group 62 XOMA XOMA 62 Inc. NASDAQ XNPT 62 Femring ® 62 Drug Fails 62 INCY 62 MAA submission 62 Meritage Pharma 62 TRBN 62 Immunomedics 62 PPD Nasdaq PPDI 62 Nventa 62 Receives Tentative FDA 62 Initiate Clinical Trial 62 ZymoGenetics ZGEN 62 Positive Opinion 62 FACTIVE R gemifloxacin 62 DOVP 62 Sunesis Pharmaceuticals Inc. 62 USFDA approval 62 Shire BioChem Inc. 62 BioDelivery Sciences International 62 Inflazyme 62 Phase III Pivotal 62 RDEA 62 Inflazyme Pharmaceuticals 62 Pulmonary Arterial Hypertension 62 ARCA biopharma 62 Cerimon 62 J.P. Morgan Healthcare 62 Aztreonam Lysine 62 DTC Eligibility 62 Alexza Pharma 62 Flutiform TM 62 Proprius Pharmaceuticals 62 Adolor NASDAQ ADLR 62 NASDAQ CYTX 62 NASDAQ NVAX 62 Icatibant 62 dacetuzumab collaboration 62 Aryx Therapeutics 62 ARIXTRA R 62 Scolr Pharma 62 Nasdaq ACHN 62 Senesco Technologies 62 Regeneron Pharmaceuticals 62 OLEPTRO 62 Neurodex 62 BioSante Pharmaceuticals NASDAQ BPAX 62 Enzon Pharmaceuticals Inc 62 NASDAQ AVEO 62 Durata Therapeutics 62 RECOTHROM R 61 Ziopharm Oncology 61 IV acetaminophen 61 Enzon Pharma 61 Par Pharmaceutical 61 Immunotherapeutic 61 GORX 61 Private Equity Financing 61 Increlex R 61 Simulect 61 Cypress Biosciences 61 NasdaqGM NTEC today 61 FUSILEV ® 61 Amylin Pharma 61 Nasdaq PGNX today 61 mtm laboratories 61 ZEVALIN ® 61 Vitaflo Scandinavia AB 61 Nitec 61 IDEV Technologies 61 Transave 61 Oceana Therapeutics 61 PSDV 61 Hybridon 61 Inhibitex INHX 61 Spectrum Pharmaceuticals SPPI 61 AMEX HEB 61 FDA Complete Response 61 NASDAQ IMGN 61 Somatuline Depot 61 Nascobal 61 SGXP 61 Dementia Related Psychosis 61 Noven Pharma 61 AMEX AIS 61 CRXX 61 Abstral ® 61 Curis NASDAQ CRIS 61 Tranzyme Pharma 61 Nasdaq EPCT 61 Pharmion Corporation 61 Provectus Pharmaceuticals 61 Jiangbo Pharmaceuticals 61 NASDAQ Delisting Notice 61 Telbivudine 61 Backs FY# View 61 Biomarin 61 Aflibercept 61 ViroChem Pharma Inc. 61 Vicor Technologies 61 Febuxostat 61 AKRX 61 Tranzyme 61 Fanapt iloperidone 61 Increlex TM 61 HELSINN 61 Biosante 61 THALOMID 61 MultiCell Technologies 61 ALNY 61 Novartis VIRT X 61 Accuray ARAY 61 Levocetirizine 61 Arpida Ltd. 61 Onyx Pharmaceuticals 61 Xenazine ® 61 Alfacell 61 PentaStaph 61 SuperGen 61 Azactam 61 Savient Pharma 61 Infergen R 61 Metaphore 61 MacroChem Corporation 61 Alnylam ALNY 61 Oracea ® 61 HaptoGuard 61 Zentaris 61 LymphoStat B TM 61 Vertex Pharmaceuticals NASDAQ VRTX 61 Fortical R 61 Tobira Therapeutics 61 Lifts FY# Outlook 61 Phase 1b Clinical Trial 61 TSPT 61 DepoMed Inc. 61 EntreMed Inc. 61 Pennsaid R 61 Targanta Therapeutics Corporation 61 Gemin X Pharmaceuticals 61 Acorda Therapeutics NASDAQ ACOR 61 pradefovir 61 Targacept TRGT 61 MacroMed 61 Catalyst Biosciences 61 FOLOTYN ® 61 Aloprim TM allopurinol sodium 61 Xyzal R 61 Cypress Bioscience 61 Celmed 61 Wound Dressing 61 PDL Biopharma 61 Syntonix Pharmaceuticals 61 Novadel 61 GATTEX TM 61 Sumatriptan Succinate 61 ARXT 61 NASDAQ ENDP 61 Oxigene 61 SGX Pharmaceuticals 61 AltaRex 61 Nasdaq AMAG 61 BTRX 61 VPHM 61 BioGlue R 61 NASDAQ PARD 61 AMEVIVE 61 Oasmia 61 Progenics Pharmaceuticals Inc 61 Vicriviroc 61 Transcept Pharma 61 XenoPort 61 QLTI 61 Hemispherx Biopharma 61 Adolor Corporation 61 Micromet MITI 61 Barrier Therapeutics 61 ZALBIN ™ 61 Presents Positive 61 Somatuline Autogel 61 AutoImmune 61 Receives CE Marking 61 IntraBiotics 61 Mln Private Placement 61 Pipex Pharmaceuticals 61 DeveloGen 61 Inspire Pharmaceuticals Inc 61 Talabostat 61 NASDAQ ALIM 61 Therapeutic Competitors companiesandmarkets.com adEgemonye 61 Trubion Pharmaceuticals Inc. 61 Faropenem 61 ISPH 61 BioGeneriX 61 IV Busulfex 61 GlaxoSmithKline plc LON GSK 61 Ganciclovir 61 Advancis Pharmaceutical Corporation 61 Investigational Compound 61 PDGI 61 OncoGenex Pharmaceuticals 61 Elusys 61 IntelliPharmaCeutics 61 R MSCRAMM 61 Albugon 61 CIP ISOTRETINOIN 61 LEVADEX TM 61 Cardioxyl Pharmaceuticals 61 THRX 61 AVEO Pharmaceuticals 61 ONTAK 61 Million Convertible Debt 61 Oxis International 61 Summary Genmab 61 Lilly Cymbalta 61 Alimera Sciences Inc. 61 GENR 61 Aloprim 61 VISICOL R 61 Maribavir 61 Nascobal R 61 NASDAQ ENMD 61 ADVENTRX Pharmaceuticals 61 Supplemental Biologics License Application 61 AMEX ANX 61 Nastech Pharmaceutical Company 61 Sanvar 61 Salix Pharmaceuticals Ltd 61 EPIX Pharmaceuticals 61 liver resection surgeries 61 DepoDur 61 Viropharma 61 TriPath 61 Reiterates FY# Outlook 61 Onco TCS 61 Octreotide 61 topical NSAID 61 ARYx Therapeutics 61 Nasdaq Notice Regarding 61 Bendamustine 61 Xenoport Inc. 61 FermaVir 61 Non Dilutive Financing 61 Non Dilutive 61 Inc. NASDAQ ZLCS 61 Feraheme ® 61 CRME 61 NitroMist TM 61 Aganocide 61 Molecular Insight 61 Reaffirms FY# Guidance 61 Biological License Application 61 HuMax TAC 61 Sagent Pharmaceuticals Announces 61 personalized cellular immunotherapy 61 Thalomid ® 61 etrials Worldwide 61 Par Pharmaceutical PRX 61 Mg Usa 61 QRxPharma 61 Oxxon 61 Application MAA 61 ANIK 61 GLASSIA 61 CLDA 61 Mometasone Furoate 61 ZIOPHARM Oncology 61 Ventrus Biosciences 61 TapImmune 61 Draxis Health 61 XTL Biopharmaceuticals Ltd. 61 Expression Genetics 61 WILEX AG 61 VentiRx Pharmaceuticals 61 A.P. Pharma 61 Othera Pharmaceuticals Inc. 61 NASDAQ BIOD 61 CYTR 61 License Option Agreement 61 Cima Labs 61 Patient Enrolment 61 Metabasis stockholders 61 Bradmer Pharmaceuticals 61 Penwest Pharmaceuticals Co. 61 SCRX 61 Noven Therapeutics 61 ZGEN 61 Bazedoxifene 61 Aloxi injection 61 OMRIX Biopharmaceuticals Inc. 61 Nasdaq ADLR 61 Poniard Pharmaceuticals PARD 61 ALTANA Pharma 61 Ropren 60 MitoKor 60 rasagiline tablets 60 methylnaltrexone 60 Acetavance TM 60 Coley Pharmaceutical 60 Agile Therapeutics 60 Removab 60 ALVESCO R 60 Initiates Phase 2b 60 SGMO 60 IDM Pharma 60 Aegera 60 EpiTherapeutics 60 ONTY 60 Bovie Medical 60 Milnacipran 60 Akorn Inc. 60 Array BioPharma ARRY 60 Backs FY# Outlook 60 MOVIPREP R 60 Voltaren Gel 60 NASDAQ SCLN 60 Esprit Pharma 60 Encysive 60 Alimera Sciences Inc 60 GeoVax Labs 60 NASDAQ ARIA 60 Ketotransdel TM 60 XIAFLEX TM 60 Synergy Pharmaceuticals 60 Momenta Pharma 60 Investorideas.com newswire BioSante PharmaceuticalLarne Holyhead 60 Urigen 60 VIVITROL ® 60 Complete Response 60 Agenus 60 Omrix Biopharma 60 Incyte 60 Metabasis Therapeutics Inc. 60 REG1 Anticoagulation System 60 topical non steroidal 60 Ocrelizumab 60 Idenix 60 Ceragenix 60 Allos Therapeutics 60 StromaCel Inc. 60 BioSphere Medical 60 Fesoterodine 60 Gestiva TM 60 Initiates Clinical Trial 60 Accelerated Approval 60 GRAS Status 60 SPL# Gel vaginal microbicide 60 RPRX 60 Through Glycoscience R 60 BiolineRX 60 oxymorphone ER 60 PHRM 60 Synalloy Corporation Announces 60 CorMedix 60 Nasdaq BCRX 60 SinuNase 60 acetonide FA 60 Lipid Sciences 60 IGI Laboratories 60 FENTORA 60 MSCRAMM ® 60 Radient Pharma 60 AEGR 60 Busulfex 60 ENZN 60 JDS Pharmaceuticals 60 ImmunoGen IMGN 60 Orexigen Therapeutics OREX 60 Inc. NASDAQ IDIX 60 Rotigotine 60 Ofirmev 60 Eyetech Pharmaceuticals Inc. 60 Adherex 60 Nasdaq MBRX 60 NYSE Amex Listing 60 PainCare Holdings 60 Nasdaq VRTX 60 Pfizer Lyrica 60 CELGENE 60 Javelin Pharmaceuticals AMEX JAV 60 Begins Dosing 60 Rapaflo 60 Expedited Review 60 TargeGen 60 TESARO 60 KRN# 60 NASDAQ CYPB 60 Janssen Alzheimer Immunotherapy 60 Phase 2a Clinical Trial 60 Organon Pharmaceuticals 60 Ivivi Technologies 60 Personalized Immunotherapy 60 Oncothyreon Inc 60 Abbott ABT 60 Dalbavancin 60 Nasdaq PARD 60 TransPharma 60 Cequent Pharmaceuticals 60 Reaffirms FY# Outlook 60 Kineret R 60 Ixempra 60 BioSante Pharmaceuticals Announces 60 Nasdaq MOGN 60 Stellar Biotechnologies 60 Brovana 60 NEXM 60 NUCRYST Pharmaceuticals 60 SSRX 60 IOMI 60 YONDELIS 60 ImmunoGen Inc. 60 Lifts FY# Guidance 60 Diatos SA 60 Belimumab 60 Protein Design 60 Nasdaq OPTR 60 Presidio Pharmaceuticals 60 glucokinase activator 60 alvimopan 60 Inc. NASDAQ BPAX 60 USFDA nod 60 Medicis Pharmaceutical Corp 60 Lpath 60 Anidulafungin 60 Vnus 60 NASDAQ ENZN 60 Corautus Genetics 60 JAK2 Inhibitor 60 Nasdaq Delisting Notice 60 Avanir Pharmaceuticals AVNR 60 Adventrx Pharmaceuticals 60 FDA Clearance 60 Wyeth Progenics 60 miconazole Lauriad ® 60 Vernakalant 60 Questcor Pharma 60 VALSTAR 60 ZIOP 60 Flamel Technologies Announces 60 Entry Inhibitor 60 Protalex 60 Actelion Ltd 60 FY# Guidance 60 Nascobal ® 60 Cefprozil 60 NASDAQ CLDX 60 Cerexa Inc. 60 CRXL 60 AMEX RGN 60 Neurobiological Technologies Inc. 60 Auxilium Pharmaceuticals Inc 60 NeurAxon Inc. 60 NASDAQ STAA 60 markets COLAZAL 60 Silodosin 60 Draxis 60 Efudex 60 Nasdaq Listing Requirements 60 Questcor Pharmaceuticals QCOR 60 Cadence Pharmaceuticals Inc. 60 Dr. Cauwenbergh 60 Acadia Pharmaceuticals ACAD 60 Xenon Pharmaceuticals 60 HCl Injection 60 Arixtra ® 60 Alexza Pharmaceuticals ALXA 60 TSX TTH 60 CollaGenex Pharmaceuticals 60 OTC BB PVCT 60 Theravance THRX 60 Nasdaq VNDA 60 Cellgate 60 rilonacept 60 Juergen Engel Ph.D. 60 IDIX 60 Ultracet R 60 Terminate Merger Agreement 60 OMNARIS Nasal Spray